03/06/2025 3:08 PM | Contineum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/06/2025 3:10 PM | Contineum Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2025 3:13 PM | Contineum Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025 9:50 AM | Contineum Therapeutics (Subject) SECTORAL ASSET MANAGEMENT INC (Filed by)
| Form SCHEDULE 13G/A | |
01/31/2025 3:35 PM | Contineum Therapeutics (Issuer) Stengone Carmine N. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 3:38 PM | Contineum Therapeutics (Issuer) Huhn Stephen L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 3:38 PM | Contineum Therapeutics (Issuer) Lorrain Daniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 3:40 PM | Contineum Therapeutics (Issuer) Slover Peter T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2024 4:06 PM | Contineum Therapeutics (Issuer) Lorrain Daniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2024 4:07 PM | Contineum Therapeutics (Issuer) Lorrain Daniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 4:05 PM | Contineum Therapeutics (Subject) Lorrain Daniel S. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for CTNM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
11/06/2024 3:08 PM | Contineum Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 3:10 PM | Contineum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024 11:46 AM | Contineum Therapeutics (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
08/14/2024 5:03 PM | Contineum Therapeutics (Issuer) Huhn Stephen L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 11:46 AM | Contineum Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024 11:19 AM | Contineum Therapeutics (Filer)
| Form 8-K/A | |
06/24/2024 3:20 PM | Boyce Sarah (Reporting) Contineum Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/24/2024 3:25 PM | Boyce Sarah (Reporting) Contineum Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 4:43 PM | Contineum Therapeutics (Issuer) Healy John Stephen (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/03/2024 4:46 PM | Contineum Therapeutics (Issuer) Healy John Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:53 PM | Contineum Therapeutics (Issuer) Schimmelpennink Evert B. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:54 PM | Brady Todd R. (Reporting) Contineum Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:54 PM | Contineum Therapeutics (Issuer) Lyons-Williams Lori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:55 PM | Contineum Therapeutics (Issuer) Ware Olivia C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:56 PM | Contineum Therapeutics (Issuer) Ignelzi Troy A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:56 PM | Contineum Therapeutics (Issuer) Huhn Stephen L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:58 PM | Contineum Therapeutics (Issuer) Lorrain Daniel S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:58 PM | Contineum Therapeutics (Issuer) Slover Peter T (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:59 PM | Contineum Therapeutics (Issuer) Stengone Carmine N. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:00 PM | Contineum Therapeutics (Issuer) Ignelzi Troy A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 6:03 PM | Contineum Therapeutics (Issuer) Ignelzi Troy A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/15/2024 3:38 PM | Contineum Therapeutics (Subject) SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
04/15/2024 3:20 PM | Contineum Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |